Inspecs Group plc (SPEC) - Net Assets
Based on the latest financial reports, Inspecs Group plc (SPEC) has net assets worth GBX89.10 Million GBX (≈ $10.84K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX203.83 Million ≈ $24.80K USD) and total liabilities (GBX114.73 Million ≈ $13.96K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Inspecs Group plc (SPEC) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX89.10 Million |
| % of Total Assets | 43.71% |
| Annual Growth Rate | 60.61% |
| 5-Year Change | -32.32% |
| 10-Year Change | N/A |
| Growth Volatility | 267.24 |
Inspecs Group plc - Net Assets Trend (2016–2024)
This chart illustrates how Inspecs Group plc's net assets have evolved over time, based on quarterly financial data. Also explore Inspecs Group plc total assets for the complete picture of this company's asset base.
Annual Net Assets for Inspecs Group plc (2016–2024)
The table below shows the annual net assets of Inspecs Group plc from 2016 to 2024. For live valuation and market cap data, see Inspecs Group plc (SPEC) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX98.69 Million ≈ $12.01K |
-4.67% |
| 2023-12-31 | GBX103.52 Million ≈ $12.60K |
-20.43% |
| 2022-12-31 | GBX130.09 Million ≈ $15.83K |
-10.42% |
| 2021-12-31 | GBX145.22 Million ≈ $17.67K |
-0.41% |
| 2020-12-31 | GBX145.82 Million ≈ $17.74K |
+365.16% |
| 2019-12-31 | GBX31.35 Million ≈ $3.81K |
+38.01% |
| 2018-12-31 | GBX22.71 Million ≈ $2.76K |
+16.19% |
| 2017-12-31 | GBX19.55 Million ≈ $2.38K |
+777.26% |
| 2016-12-31 | GBX2.23 Million ≈ $271.14 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Inspecs Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 477869900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX1.02 Million | 1.03% |
| Other Components | GBX103.26 Million | 104.63% |
| Total Equity | GBX98.69 Million | 100.00% |
Inspecs Group plc Competitors by Market Cap
The table below lists competitors of Inspecs Group plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HTC Purenergy Inc.
V:HTC
|
$1.03 Million |
|
Suumaya Industries Limited
NSE:SUULD
|
$1.04 Million |
|
Cake Box Holdings PLC
LSE:CBOX
|
$1.04 Million |
|
POLAREAN IMAG.LS-00037
F:8ZF
|
$1.04 Million |
|
Trifast plc
LSE:TRI
|
$1.03 Million |
|
Value & Income Trust
LSE:VIP
|
$1.03 Million |
|
Thiensurat Public Company Limited
BK:TSR
|
$1.03 Million |
|
Shield Therapeutics plc
LSE:STX
|
$1.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Inspecs Group plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 103,517,000 to 98,686,000, a change of -4,831,000 (-4.7%).
- Net loss of 4,608,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-4.61 Million | -4.67% |
| Other Changes | GBX-223.00K | -0.23% |
| Total Change | GBX- | -4.67% |
Book Value vs Market Value Analysis
This analysis compares Inspecs Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 86.03x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 2650.83x to 86.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | GBX0.03 | GBX83.50 | x |
| 2017-12-31 | GBX0.28 | GBX83.50 | x |
| 2018-12-31 | GBX0.32 | GBX83.50 | x |
| 2019-12-31 | GBX0.44 | GBX83.50 | x |
| 2020-12-31 | GBX2.11 | GBX83.50 | x |
| 2021-12-31 | GBX1.37 | GBX83.50 | x |
| 2022-12-31 | GBX1.28 | GBX83.50 | x |
| 2023-12-31 | GBX1.02 | GBX83.50 | x |
| 2024-12-31 | GBX0.97 | GBX83.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Inspecs Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.32%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 2.23x
- Recent ROE (-4.67%) is below the historical average (3.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 31.80% | 3.21% | 1.54x | 6.43x | GBX485.82K |
| 2017 | -17.09% | -6.79% | 0.70x | 3.57x | GBX-5.30 Million |
| 2018 | 15.40% | 6.11% | 0.83x | 3.05x | GBX1.23 Million |
| 2019 | 15.67% | 8.02% | 0.86x | 2.28x | GBX1.78 Million |
| 2020 | -4.49% | -13.79% | 0.15x | 2.13x | GBX-21.12 Million |
| 2021 | -2.77% | -2.21% | 0.56x | 2.25x | GBX-18.55 Million |
| 2022 | -4.86% | -3.14% | 0.69x | 2.25x | GBX-19.33 Million |
| 2023 | -0.96% | -0.49% | 0.92x | 2.14x | GBX-11.35 Million |
| 2024 | -4.67% | -2.32% | 0.90x | 2.23x | GBX-14.48 Million |
Industry Comparison
This section compares Inspecs Group plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $588,255,333
- Average return on equity (ROE) among peers: 12.69%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Inspecs Group plc (SPEC) | GBX89.10 Million | 31.80% | 1.29x | $1.03 Million |
| Advanced Medical Solutions Group plc (AMS) | $152.44 Million | 13.21% | 0.11x | $6.32 Million |
| ConvaTec Group PLC (CTEC) | $1.61 Billion | 3.91% | 1.23x | $49.81 Million |
| Tristel (TSTL) | $2.63 Million | 20.95% | 0.78x | $2.36 Million |
About Inspecs Group plc
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT,… Read more